Sight Sciences, Inc. (SGHT) Fair Value 2026

SGHT · Medical Devices ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

7.3 /10

32 fundamental signals · 0 models active

Value Trap Risk

SAFE (19/100)

Quick Summary — As of 2026-08-28, Sight Sciences, Inc. (SGHT) trades at $8.55. QOC: 7.3/10. Value Trap Risk: 19/100 (SAFE). 0/13 models active.

Key Facts

Ticker
SGHT
Price
$8.55
Quality Score
7.3/10
Value Trap Risk
19/100
Models Active
0/13
Last Updated
Strength: 0 independent models provide multi-angle coverage
Risk: Limited model coverage (0/13) may reduce confidence

What Fair Value Does Each Model Give SGHT?

0 Intrinsic Value Models vs. Current Price ($8.55)

Core Models (Unlocked)
Model Fair Value Upside

All Models Active

All 0 models are displayed above.

What Is Sight Sciences, Inc. (SGHT) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Sight Sciences, Inc. currently lacks sufficient data across our 13-model framework. As more financial data is processed from SEC filings, our models will generate intrinsic value estimates.

What Do the Models Say About SGHT?

0 of 13 models are currently active for SGHT. See which stocks rank higher →

How Does SGHT Rank in Medical Devices?

Among 159 Medical Devices stocks, SGHT ranks #40 by Quality of Company score. CirclFi's QOC score of 7.3/10 evaluates 32 fundamental signals. A score of 7.3 indicates above-average quality.

See all Most Undervalued Medical Devices Stocks →

Sight Sciences, Inc.'s positioning within the Medical Devices segment means that pipeline depth and stage distribution plays an outsized role in fundamental analysis. The sector's unique characteristics — including orphan drug designation — shape both the opportunity set and risk profile.

Is SGHT a Value Trap?

CirclFi's Value Trap algorithm assigns SGHT a score of 19/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

0 of 13 models are active for Sight Sciences, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, Sight Sciences, Inc. earns a quality score of 7.3/10. This respectable rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every SGHT valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Sight Sciences, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Devices Stocks Should You Also Analyze?

11 related Medical Devices stocks with 13-model coverage

SRTSSensus Healthcare, Inc.QOC 7.3AORTArtivion, Inc.QOC 7.3VREXVarex Imaging CorporationQOC 7.3LUNGPulmonx CorporationQOC 7.2SNWVSANUWAVE Health, Inc.QOC 7.4IARTIntegra LifeSciences Holdings CorporationQOC 7.1AHCOAdaptHealth Corp.QOC 6.3ELUTElutia Inc.QOC 5.2ITOCiTonic Holdings Ltd.QOC 2.5IRMDIRADIMED CORPORATIONQOC 9.8PODDInsulet CorporationQOC 9.6

Read investment analysis: SRTS · AORT · VREX · LUNG · SNWV · IART · AHCO · ELUT · ITOC · IRMD · PODD

Which Other Stocks Have a Similar Quality Score to SGHT?

7 companies across all industries closest to SGHT’s Quality of Company score of 7.3/10.

VSECVSE CorporationQOC 7.3CPKChesapeake Utilities CorporationQOC 7.3BMNMBimini Capital Management, Inc.QOC 7.3RYZRyerson Holding CorporationQOC 7.3TRLVTrulieve Cannabis Corp.QOC 7.3GDOTGreen Dot CorporationQOC 7.3NVDANVIDIA CorporationQOC 10.0

Read investment analysis: VSEC · CPK · BMNM · RYZ · TRLV · GDOT · NVDA

Where Does SGHT Sit in CirclFi's Medical Devices Rankings?

SGHT is ranked against every other Medical Devices stock CirclFi covers in each of these screens.

See all Medical Devices stocks ranked →

What Else Do Investors Ask About Sight Sciences, Inc.’s Valuation?

What is Sight Sciences, Inc.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for Sight Sciences, Inc. (SGHT). The Quality of Company score is 7.3/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is SGHT overvalued or undervalued right now?

At $8.55, 0 of 0 active models suggest SGHT may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits Sight Sciences, Inc.'s business model in Medical Devices.

What does a Quality of Company score of 7.3 mean for SGHT?

Sight Sciences, Inc.'s QOC of 7.3/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on SGHT?

CirclFi analyzes SGHT with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 0 of 13 are active for this stock. Read the full methodology →

Is SGHT a value trap in 2026?

Sight Sciences, Inc.'s Value Trap score is 19/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns Sight Sciences, Inc. (SGHT) a Quality of Company score of 7.3/10 across 32 fundamental signals as of 2026-08-28.” Source: circlfi.com/stock/SGHT/ · Methodology
Primary sources for this SGHT valuation
  • Financial statements: Sight Sciences, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001531177) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for SGHT as of ; valuations recomputed .